Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2019 | 12-2018 | 06-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,250 | 14,882 | 3,601 | -19,300 | -54,690 |
| Depreciation Amortization | 18,512 | 7,672 | 8,741 | 2,900 | 4,965 |
| Other Working Capital | 45,074 | 46,294 | -71,550 | -44,530 | -19,192 |
| Other Operating Activity | -1,221 | -1,818 | 20,789 | 20,470 | 14,595 |
| Operating Cash Flow | $39,115 | $67,030 | $-38,419 | $-40,460 | $-54,322 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,435 | -828 | -1,203 | -830 | -3,350 |
| Other Investing Activity | -67,493 | -68,633 | 29,877 | 18,430 | -29,949 |
| Investing Cash Flow | $-68,928 | $-69,461 | $28,674 | $17,600 | $-33,299 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 87,097 | -868 | 72,303 | -810 | 1,034 |
| Financing Cash Flow | $87,097 | $-868 | $72,303 | $-810 | $1,034 |
| Exchange Rate Effect | 6 | -3 | -31 | -20 | 77 |
| Beginning Cash Position | 170,592 | 171,201 | 117,352 | 118,500 | 198,827 |
| End Cash Position | 227,233 | 167,899 | 179,883 | 94,810 | 112,315 |
| Net Cash Flow | $56,641 | $-3,302 | $62,499 | $-23,690 | $-86,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,115 | 67,030 | -38,419 | -40,460 | -54,322 |
| Free Cash Flow | 39,115 | 67,030 | -38,419 | -40,460 | -54,322 |